Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia

©Copyright 2023 by Turkish Society of Hematology Turkish Journal of Hematology, Published by Galenos Publishing House..

Objective: Febrile neutropenia (FN) is an important complication that causes high rates of morbidity and mortality in patients with malignancies. We aimed to investigate the etiology, epidemiological distribution and its change over the years, clinical courses, and outcomes of FN in children with acute leukemia.

Materials and Methods: We retrospectively analyzed the demographic data, clinical characteristics, laboratory results, severe complications, and mortality rates of pediatric patients with FN between January 2010 and December 2020.

Results: In 153 patients, a total of 450 FN episodes (FNEs) occurred. Eighty-four (54.9%) of these patients were male, the median age of the patients was 6.5 (range: 3-12.2) years, and 127 patients (83%) were diagnosed with acute lymphoblastic leukemia. Fever with a focus was found in approximately half of the patients, and an etiology was identified for 38.7% of the patients. The most common fever focus was bloodstream infection (n=74, 16.5%). Etiologically, a bacterial infection was identified in 22.7% (n=102), a viral infection in 13.3% (n=60), and a fungal infection in 5.8% (n=26) of the episodes. Twenty-six (23.2%) of a total of 112 bacteria were multidrug resistant (MDR) The rate of severe complications was 7.8% (n=35) and the mortality rate was 2% (n=9). In logistic regression analysis, refractory/relapsed malignancies and high C-reactive protein (CRP) at first admission were found to be the most important independent risk factors for mortality. Prolonged neutropenia after chemotherapy, diagnosis of acute myeloid leukemia, identification of fever focus or etiological agents, invasive fungal infections, polymicrobial infections, and need for intravenous immunoglobulin treatment increased the frequency of severe complications.

Conclusion: We found that there was no significant change in the epidemiological distribution or frequency of resistant bacteria in our center in the last 10 years compared to previous years. Prolonged duration of fever, relapsed/refractory malignancies, presence of fever focus, and high CRP level were significant risk factors for poor clinical course and outcome.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Turkish journal of haematology : official journal of Turkish Society of Haematology - 40(2023), 3 vom: 31. Aug., Seite 143-153

Sprache:

Englisch

Beteiligte Personen:

Erbaş, İrem Ceren [VerfasserIn]
Çakıl Güzin, Ayşe [VerfasserIn]
Özdem Alataş, Şilem [VerfasserIn]
Karaoğlu Asrak, Hatice [VerfasserIn]
Akans, İlknur [VerfasserIn]
Akyol, Şefika [VerfasserIn]
Özlü, Canan [VerfasserIn]
Tüfekçi, Özlem [VerfasserIn]
Yılmaz, Şebnem [VerfasserIn]
Ören, Hale [VerfasserIn]
Belet, Nurşen [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Febrile neutropenia
Infectious diseases
Journal Article
Mortality
Pediatric cancer
Risk factors

Anmerkungen:

Date Completed 01.09.2023

Date Revised 06.09.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.4274/tjh.galenos.2023.2023.0185

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360253180